Dormant Company Accounts - PHARMACEUTICAL PRESS LIMITED

Dormant Company Accounts - PHARMACEUTICAL PRESS LIMITED


true 2017-03-01 2018-02-28 false 07165037 uk-bus:Director1 2017-03-01 2018-02-28 07165037 uk-bus:Director2 2017-03-01 2018-02-28 07165037 2017-03-01 2018-02-28 07165037 2018-02-28 07165037 uk-bus:EntityHasNeverTraded 2017-03-01 2018-02-28 07165037 uk-bus:FRS102 2017-03-01 2018-02-28 07165037 uk-bus:FullAccounts 2017-03-01 2018-02-28 07165037 uk-bus:AuditExempt-NoAccountantsReport 2017-03-01 2018-02-28 07165037 2017-02-28 07165037 uk-bus:OrdinaryShareClass1 2017-03-01 2018-02-28 07165037 uk-bus:OrdinaryShareClass2 2017-03-01 2018-02-28 07165037 uk-bus:OrdinaryShareClass3 2017-03-01 2018-02-28 07165037 uk-bus:PreferenceShareClass1 2017-03-01 2018-02-28 07165037 uk-bus:PreferenceShareClass2 2017-03-01 2018-02-28 07165037 uk-bus:PreferenceShareClass3 2017-03-01 2018-02-28 07165037 uk-core:ShareCapitalPreferenceShares 2018-02-28 07165037 uk-core:ShareCapitalPreferenceShares 2017-02-28 iso4217:GBP xbrli:shares

Registered Number 07165037

PHARMACEUTICAL PRESS LIMITED

Dormant Accounts

28 February 2018

PHARMACEUTICAL PRESS LIMITED Registered Number 07165037

Balance Sheet as at 28 February 2018

2018 2017
£ £
Called up share capital not paid
1000
1000
Net assets
1000
1000
Issued share capital
1000 Ordinary Shares of £ 1 each 1000 1000
Total Shareholder funds
1000
1000

STATEMENTS

  1. For the year ending 28 February 2018 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 30 September 2018

And signed on their behalf by:
Paul Bennett, Director